ES
Eagle Strategies’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Sell |
1,734
-29
| -2% | -$5.38K | 0.05% | 185 |
|
|
2025
Q1 | $369K | Sell |
1,763
-4
| -0.2% | -$838 | 0.06% | 157 |
|
|
2024
Q4 | $314K | Sell |
1,767
-73
| -4% | -$13K | 0.05% | 173 |
|
|
2024
Q3 | $363K | Sell |
1,840
-47
| -2% | -$9.28K | 0.07% | 156 |
|
|
2024
Q2 | $324K | Sell |
1,887
-9,617
| -84% | -$1.65M | 0.06% | 162 |
|
|
2024
Q1 | $2.09M | Buy |
11,504
+9,574
| +496% | +$1.74M | 0.47% | 55 |
|
|
2023
Q4 | $299K | Buy |
1,930
+20
| +1% | +$3.1K | 0.06% | 159 |
|
|
2023
Q3 | $285K | Sell |
1,910
-590
| -24% | -$88K | 0.07% | 152 |
|
|
2023
Q2 | $337K | Buy |
2,500
+1
| +0% | +$135 | 0.08% | 141 |
|
|
2023
Q1 | $398K | Buy |
2,499
+173
| +7% | +$27.6K | 0.1% | 126 |
|
|
2022
Q4 | $376K | Buy |
2,326
+290
| +14% | +$46.9K | 0.11% | 116 |
|
|
2022
Q3 | $273K | Buy |
+2,036
| New | +$273K | 0.14% | 83 |
|